94MO Quality of Life (qol) with Fulvestrant (ful)/palbociclib (PAL) Versus FUL/placebo (PBO) in Postmenopausal Women with Hormone Receptor (HR)+/HER2- Endocrine Sensitive Advanced Breast Cancer (ABC): Results from GEICAM/2014-12 (FLIPPER) Study

A. Tibau, M. T. Martinez,M. Ramos,L. De la Cruz-Merino,A. Santaballa,M. O'Connor,N. Martinez-Janez, F. Moreno, I. Fernandez-Perez,J. A. Virizuela,J. Alarcon,J. de la Haba-Rodriguez,P. Sanchez-Rovira, C. R. Albacar,C. Bueno,C. Kelly,M. Casas,S. Bezares, L. Rosell,J. Albanell

Annals of oncology（2021）

引用 1|浏览39

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要